Clinicopathological parameters | Calpain II expression | ||
---|---|---|---|
Positive (%) n = 64 | Negative (%) n = 19 | P value | |
ER | 0.580 | ||
 Positive | 35 (54.7) | 9 (47.4) | |
 Negative | 29 (45.3) | 10 (52.6) | |
HER2 | 0.597 | ||
 Positive | 21 (32.8) | 5 (26.3) | |
 Negative | 43 (67.2) | 14 (73.7) | |
pAKT | 0.029 a | ||
 Positive | 50 (78.1) | 10 (52.6) | |
 Negative | 14 (21.9) | 9 (47.4) | |
pmTOR | 0.011 a | ||
 Positive | 52 (81.3) | 10 (52.6) | |
 Negative | 12 (18.8) | 9 (47.4) | |
p4E-BP1 | < 0.001 a | ||
 Positive | 52 (81.3) | 6 (31.6) | |
 Negative | 12 (18.8) | 13 (68.4) | |
p-p70S6K | 0.003 a | ||
 Positive | 52 (81.3) | 9 (47.4) | |
 Negative | 12 (18.8) | 10 (52.6) | |
Stage | 0.773 | ||
 Stage I | 7 (10.9) | 1 (5.3) | |
 Stage II | 37(57.8) | 14 (73.7) | |
 Stage III | 20 (31.3) | 4 (21.2) | |
Grade | 0.568 | ||
 Grade I | 16 (25.0) | 3 (15.8) | |
 Grade II | 35 (54.7) | 12 (63.2) | |
 Grade III | 13 (20.3) | 4 (21.1) | |
Nodal status | 0.876 | ||
 Positive | 45 (70.3) | 13 (68.4) | |
 Negative | 19 (29.7) | 6 (31.6) | |
Distant metastasis | 0.122 | ||
 Positive | 26 (40.6) | 4 (21.1) | |
 Negative | 38 (59.4) | 15 (78.9) | |
Tumor size | 0.013 a | ||
 ≦4 cm | 34 (53.1) | 4 (21.1) | |
 > 4 cm | 30 (46.9) | 15 (78.9) | |
Age | 0.653 | ||
 ≦55 yrs | 44 (68.8) | 12 (63.2) | |
 > 55 yrs | 20 (31.3) | 7 (36.8) |